arrow
M

Michael Manning

university of arizona college of medicine
H指数:19
被引数:1,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema Attacks

奥马珠单抗口服制剂对遗传性血管性水肿发作相关焦虑的影响

2026-03-050
OAAI
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension

Sebetralstat的长期安全性与有效性:KONFIDENT-S开放标签扩展研究的期中分析

2025-08-290
OAAI
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis

多尼达罗森治疗既往长期预防治疗的患者中的遗传性血管性水肿

2025-07-170
PREAI
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema

伯罗特拉斯特每日一次给药在遗传性血管性水肿患者中的长期安全性和有效性

2025-06-070
PREAI
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema

donidalorsen对遗传性血管性水肿的前激肽释放酶抑制的2期开放标签扩展研究

2023-11-275
OA
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
LANCET
IF88.5
2023-04-0145
PRE
Inhibition of Prekallikrein for Hereditary Angioedema
2022-03-1743
OA
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (vol 16, 86, 2021)
2021-07-280
OAAI
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
2021-02-1523
OAAI
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings
2019-07-0111
OAAI
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks A Randomized Clinical Trial
2018-11-27203
OAAI
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
2018-09-0169
OAAI
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
2017-03-23178
OAAI